Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

DNA Microarrays

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Same site recurrence following standardized high ligation and stripping of the great saphenous vein - 5-year results of the LaVaCro trial.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

Same author

VASA. Zeitschrift fur Gefasskrankheiten·2025

Same author

Microcirculation disorders of the skin.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2024

Same author

Effects of Extracorporeal Photopheresis on Quality of Life and the Course of Diseases in Patients With Mycosis Fungoides and Graft-Versus-Host Disease: A Single-Center Analysis.

Cureus·2023

Same author

Optimisation of intermittent pneumatic compression in patients with lymphoedema of the legs

European journal of dermatology : EJD·2023

Same author

[Digital dermatology].

Dermatologie (Heidelberg, Germany)·2022

Search research articles

Related Experiment Video

Updated: Sep 28, 2025

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza

Published on: June 9, 2011

Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer's

Angus Forster¹, Michael Junger¹

¹Research & Development, Vaxxas Pty Ltd., Brisbane, Australia.

Human Vaccines & Immunotherapeutics

|March 31, 2022

Summary

Microarray patch (MAP) technology offers needle-free vaccine delivery, improving safety and accessibility. Wider adoption requires addressing challenges in manufacturing, regulation, and market acceptance for both routine use and pandemic preparedness.

Keywords:

MAP Microarray patch influenza needle-Free pandemic preparedness pandemic response vaccine vaccine delivery

More Related Videos

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

Related Experiment Videos

Last Updated: Sep 28, 2025

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza

Published on: June 9, 2011

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

Area of Science:

Biotechnology
Vaccinology
Medical Devices

Background:

Microarray patch (MAP) technology is advancing needle-free vaccine delivery.
MAPs offer benefits like dose-sparing, cold-chain independence, enhanced safety, and self-administration.
This technology is a priority for overcoming vaccination barriers and improving global vaccine access.

Purpose of the Study:

To highlight the potential of MAP technology for pandemic response and routine vaccination.
To emphasize the need for increased awareness and understanding among stakeholders.
To identify key challenges hindering commercialization and widespread adoption.

Main Methods:

Review of current advancements in MAP technology.
Analysis of the benefits and drivers for MAP platform adoption.
Identification of commercialization and adoption challenges.

Main Results:

Vaxxas has developed a strong evidence base for its high-density (HD) MAP platform and is scaling up manufacturing.
MAP technology presents significant advantages for vaccine delivery, including potential dose-sparing and elimination of cold chains.
Key challenges include market acceptance, production scale-up, regulatory hurdles, and capital investment.

Conclusions:

MAP technology holds significant promise for revolutionizing vaccine delivery, especially during pandemics.
Accelerated adoption requires greater stakeholder awareness and proactive engagement with regulatory bodies and supply chains.
Overcoming commercialization barriers is crucial for realizing the full potential of MAPs in global health.